ACQUIRED · 2021
Who Acquired Cordis (Cardinal Health)?
Hellman & Friedman · $1.00B· 14.3× EBITDA
The acquisition
Cordis (Cardinal Health) was acquired by Hellman & Friedman in 2021 for $1.00B. The deal was priced at 14.3× EBITDA / 1.30× revenue.
Cordis (Cardinal Health) at time of acquisition
Revenue
$750.0M
EBITDA
$70.0M
Deal value
$1.00B
EV / EBITDA
14.3×
Similar medical devices acquisitions
- Owen Mumford Holdings · acquired by Embecta in 2026 · $201.0M
- Acera Surgical · acquired by Solventum in 2025 · $725.0M
- Alydia Health (Organon JADA System) · acquired by Laborie Medical Technologies in 2025 · $440.0M
- B Medical Systems (Azenta) · acquired by THELEMA S.A. R.L. in 2025 · $63.0M
- BIOTRONIK Vascular Intervention Business · acquired by Teleflex, Inc. in 2025 · $875.9M
Run a valuation for a similar medical devices business
Three fields, instant range, backed by 25,592 real M&A transactions including this one.
Open the medical devices calculator →More on medical devices valuations
- Medical Devices valuation calculator· head-term variant
- Medical Devices median multiples· real-deal benchmarks
- How to value a medical devices· long-form guide
Sourced from Press releases and bond rating releases. Full deal page.
Citation: ExitValue.ai. (2021). Cordis (Cardinal Health) acquired by Hellman & Friedman. https://exitvalue.ai/acquired/cordis-cardinal-health